Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 20:04 ET | Source: Robbins LLP

MEDP Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action lawsuit Filed Against Medpace Holdings Inc.

Robbins LLP is Investigating Allegations that Medpace Holdings Inc. (MEDP) Misled Investors Regarding its Expected Book-to-Bill Ratio
April 06, 2026 13:17 ET | Source: Robbins LLP

GOSS Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Gossamer Bio, Inc. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Gossamer Bio, Inc. (GOSS) Misled Investors Regarding the Viability of its PROSERA Study
March 31, 2026 14:43 ET | Source: Robbins LLP

SLNO Stockholders Have Rights – If You Lost Money Investing in Soleno Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is Investigating Allegations that Soleno Therapeutics SLNO Misled Investors Regarding the Viability and Efficacy of its Phase 3 Clinical Trial
March 09, 2026 12:23 ET | Source: Robbins LLP

BSX Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Boston Scientific Corporation Class Action Lawsuit

Robbins LLP is Investigating Allegations that Boston Scientific Corporation (BSX) Misled Investors Regarding Projected Revenue
March 02, 2026 14:51 ET | Source: Robbins LLP

ZYXIQ Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Fraud Class Action on Behalf of Zynex, Inc. Stockholders

Robbins LLP is Investigating Allegations that Zynex, Inc. (ZYXIQ) Filed False Claims and Failed to Comply with Industry Regulations
February 24, 2026 16:52 ET | Source: Robbins LLP

Robbins LLP Urges BRBR Investors with Large Losses in BellRing Brands, Inc. to Contact the Firm for Information About the Class Action Lawsuit

Robbins LLP is Investigating Allegations that BellRing Brands, Inc. (BRBR) Misled Investors Regarding its Sales During the Class Period
February 18, 2026 14:11 ET | Source: Robbins LLP

Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO

Robbins LLP is Investigating Allegations that Mereo BioPharma Group plc (MREO) Misled Investors Regarding Phase 3 Orbit and Cosmic Studies for Setrusumab
February 17, 2026 14:29 ET | Source: Robbins LLP

Robbins LLP Urges AGL Stockholders with Large Losses to Contact the Firm for Information About Leading the Agilon Health, Inc. Securities Class Action

Robbins LLP is Investigating Allegations that Agilon Health, Inc. (AGL) Misled Investors Regarding its Business Prospects
February 16, 2026 19:42 ET | Source: Robbins LLP

QURE Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the uniQure N.V. Class Action

The Allegations: Robbins LLP is Investigating Allegations that uniQure (QURE) Misled Investors Regarding the Likelihood of FDA Approval of its Drug.
February 13, 2026 14:56 ET | Source: Robbins LLP

INO Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Inovio Pharmaceuticals, Inc. Class Action

Robbins LLP is Investigating Allegations that Inovio Pharmaceuticals, Inc. (INO) Misled Investors Regarding Approval for its CELLECTRA Device